Advanced Cell Diagnostics (ACD) logo — RNA expression like you've never seen before

Advanced Cell Diagnostics (ACD)

RNA expression like you've never seen before

Founded 2006 United States Newark, United States 143 employees Series C Biotechnology, Health Care +1

General Information

Company Name Advanced Cell Diagnostics (ACD)
Founded Year 2006
Location United States Newark, United States +1
Employees 143
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Series C
Social

Get notified when Advanced Cell Diagnostics (ACD) moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Advanced Cell Diagnostics (ACD)

Advanced Cell Diagnostics (ACD) is a leading player in the biotechnology, healthcare, and pharmaceutical industries. The company, acquired by Bio-Techne, has made significant strides in personalized medicine and molecular pathology. Founded in 2006 and headquartered in Silicon Valley, ACD is spearheading the development of cell- and tissue-based research and diagnostic tests. Its breakthrough RNAscope™ technology, with over 10,000 publications, has positioned the company at the forefront of RNA analysis. The proprietary platform, capable of detecting and quantifying single molecules of RNA in situ, has paved the way for personalized medicine and advancement in drug development. With product lines such as RNAscope and BaseScope™, as well as a Professional Assay Services business, ACD offers a comprehensive catalog including >50,000 target probes and assay kits for single, duplex, and multiplex RNA analysis. Although ACD has made remarkable progress, the details of its last investment and investors are currently undisclosed. For more information, visit www.acdbio.com.

No funding data available for Advanced Cell Diagnostics (ACD) yet.

Get notified when Advanced Cell Diagnostics (ACD) raises funding

Advanced Cell Diagnostics (ACD) Alternatives & Competitors

Advanced Cell Diagnostics (ACD) vs
Eclipsebio
Eclipsebio United States

Next-generation assays. Data-driven analytics. RNA breakthroughs.

Series A
40 employees
Biotechnology, Life Sciences
Advanced Cell Diagnostics (ACD) vs

Helping Physicians Integrate Personalized Medicine into Standard Practice for Better Patient Outcome...

Biotechnology, Health Care
Advanced Cell Diagnostics (ACD) vs

Accelerating Spatial Biology.

Series D
147 employees
Biotechnology, Health Care
Also compare with: Advanced Cell Diagnostics (ACD) vs Ashion Analytics Ashion Analytics

FAQ About Advanced Cell Diagnostics (ACD)

RNA expression like you've never seen before
Advanced Cell Diagnostics (ACD) was founded in 2006.
Advanced Cell Diagnostics (ACD) is headquartered in Newark, United States.
Advanced Cell Diagnostics (ACD) operates in the following industries: Biotechnology, Health Care, Pharmaceutical.
Advanced Cell Diagnostics (ACD) has approximately 143 employees.
Top alternatives and competitors to Advanced Cell Diagnostics (ACD) include Eclipsebio, PGXL Laboratories, Lunaphore (a Bio-Techne brand), Ashion Analytics, PolyQuant. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Advanced Cell Diagnostics (ACD) and Eclipsebio are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Advanced Cell Diagnostics (ACD) and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy